logo

Biotech Stocks Facing FDA Decision In November 2019

Pending Drug Approvals of November 2019
Pending Drug Approvals of November 2019

2020 is only two months away!

So far this year in 2019, only thirty-three novel drugs have been approved compared to 47 during the same period last year (i.e., January to October 2018). Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.

Last year, a record number of 59 novel drugs won the FDA stamp of approval, representing an all-time high.

Now, let's take a look at the companies that await a ruling from the FDA in November 2019.

Share



>